Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up-Reference-Cited by-同舟云学术

Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up

Published:2021-02-25 Issue:3 Volume:133 Page:291-298
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Zandanell Stephan¹^ORCID,Strasser Michael¹,Feldman Alexandra¹,Strebinger Georg¹,Aigner Gerhild¹,Niederseer David²³^ORCID,Laimer Martin⁴^ORCID,Mussnig Birgit⁴,Paulweber Bernhard¹^ORCID,Datz Christian²^ORCID,Aigner Elmar¹^ORCID

Affiliation:

1. First Department of Medicine, Paracelsus Medical University, Salzburg, Austria

2. Department of Internal Medicine, Oberndorf Hospital, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria

3. Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, University of Zurich, Zurich, Switzerland

4. Laboratory for Immunology, Allergology & Molecular Diagnostics, Department of Dermatology, Paracelsus Medical University, Salzburg, Austria

Funder

PMU Forschungsforderungsfonds

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1885945

Reference14 articles.

1. Primary Biliary Cirrhosis

2. Antimitochondrial Antibodies in Primary Biliary Cirrhosis and Other Disorders: Definition and Clinical Relevance

3. Antimitochondrial Antibodies in Primary Biliary Cirrhosis

4. Autoantibodies in liver disease

5. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: Epitopes or epiphenomena?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid;PLOS ONE;2023-02-24

2. Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis;Frontiers in Pharmacology;2022-08-30

3. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics;Biomedicines;2022-05-31

4. Antimitochondrial Antibodies: from Bench to Bedside;Clinical Reviews in Allergy & Immunology;2021-09-29

5. Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis;Digestive Diseases and Sciences;2021-06-28